Statins not advised for use in kids with common cholesterol problems
National Lipid Association issued a statement regarding new cholesterol guidelines for children.
The National Lipid Association (NLA) has issued a statement regarding the new cholesterol guidelines for children that the American Academy of Pediatrics released on July 7. NLA said that much of the controversy surrounding the AAP guidelines appears to stem from a misinterpretation regarding the use of statins and other lipid-lowering drugs. These are options for managing specific genetic hypercholesterolemias and severe hypertriglyceridemias. Children with common dyslipidemias should not be routinely managed with drugs, as diet and exercise remain the best treatment options.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Socioeconomic Disparities Persisted Alongside Improving Vaccination Rates In US Over 11-Year Period
April 16th 2024Findings indicating that socioeconomic disparities widened gaps in vaccination timeliness signal the need for increased efforts to promote timely vaccination among children from families with lower income and those without private insurance.
FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6
March 28th 2024Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.
